35.79
+0.55(+1.56%)
Currency In USD
| Previous Close | 35.24 |
| Open | 35.4 |
| Day High | 36.41 |
| Day Low | 35.13 |
| 52-Week High | 36.41 |
| 52-Week Low | 11.26 |
| Volume | 409,534 |
| Average Volume | 2.18M |
| Market Cap | 3.06B |
| PE | -24.51 |
| EPS | -1.46 |
| Moving Average 50 Days | 28.79 |
| Moving Average 200 Days | 20.89 |
| Change | 0.55 |
If you invested $1000 in Liquidia Corporation (LQDA) since IPO date, it would be worth $3,224.32 as of December 24, 2025 at a share price of $35.79. Whereas If you bought $1000 worth of Liquidia Corporation (LQDA) shares 5 years ago, it would be worth $12,691.49 as of December 24, 2025 at a share price of $35.79.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
GlobeNewswire Inc.
Oct 27, 2025 12:30 PM GMT
MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quar
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
GlobeNewswire Inc.
Oct 07, 2025 10:30 AM GMT
MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Dev